Gender-associated features in diabetic kidney disease
DOI:
https://doi.org/10.26641/2307-0404.2024.3.313578Keywords:
diabetic kidney disease, diabetes mellitus type 2, genderAbstract
Diabetic kidney disease (DKD) is the leading cause of end-stage renal failure. Evidence indicates gender differences in the progression of this disease. This study aimed to determine gender differences in prevalence and identify gender-associated risk factors contributing to the development of diabetic kidney disease in individuals with type 2 diabetes mellitus (T2DM). The cross-sectional study included 132 patients with T2DM ranging in age from 50 to 65 years. Subjects were stratified by sex (80 women and 52 men). Gender differences have been studied in relation to the incidence and prevalence of DKD, their phenotypes and clinical manifestations, and several risk factors that have different effects on both sexes. The outcome of clinical kidney function assessment showed that 70% subjects were diagnosed with DKD (71% of women and 67% of men). The study indicated an association between the duration of T2DM and urinary albumin levels, as well as between arterial hypertension and triglyceride levels, which are independent risk factors for DKD development. Notably, older women with T2DM have a higher prevalence of DKD than older men. The albuminuric component of DKD was more frequently observed in men. Additionally, men were more likely to have adverse risk factors, including dyslipidemia, lower high-density lipoprotein cholesterol, and glomerular filtration rate, which are factors involved in the mechanisms of DKD. In summary, the results indicate that: 1) women with type 2 diabetes mellitus are at a higher risk of developing a normoalbuminuric phenotype of diabetic kidney disease, while men are at a higher risk of developing an albuminuric phenotype of diabetic kidney disease leading to renal failure and end-stage renal disease; 2) gender differences are most noticeable among older adults and may have significant implications for the development of more effective diagnostic and treatment methods for diabetic kidney disease, tailored to individual needs.
References
Xia L, Cheng L, Jiang T, et al. Estimation of the prevalence of type 2 diabetes in combination with diabetic kidney disease and identification of the associated factors in patients attending primary hospitals in Anhui Province, China. J International Medical Research. 2021;49(10):3000605211051225. doi: https://doi.org/10.1177/03000605211051225
Huang JX, Liao YF, Li YM. Clinical features and microvascular complications risk factors of early-onset type 2 diabetes mellitus. Current Medical Science. 2019;39(5):754-8. doi: https://doi.org/10.1007/s11596-019-2102-7
Deng L, Li W, Xu G. Update on pathogenesis and diagnosis flow of normoalbuminuric diabetes with renal insufficiency. Euro Journal of Medical Research. 2021;26(1):144. doi: https://doi.org/10.1186/s40001-021-00612-9
Fritz J, Brozek W, Concin H, et al. The association of excess body weight with risk of ESKD is mediated through insulin resistance, hypertension, and hyperuricemia. Journal of the American Society of Nephrology. 2022;33(7):1377-89. doi: https://doi.org/10.1681/ASN.2021091263
Bae EH, Lim SY, Kim B, et al. Effects of blood pressure according to age on end-stage renal disease deve¬lopment in patients with diabetes: a nationwide population-based cohort study. Hypertension. 2022;79(8):1765-76. doi: https://doi.org/10.1161/HYPERTENSIONAHA.121.18881
Sabbatini AR, Kararigas G. Estrogen-related mechanisms in sex differences of hypertension and target organ damage. Biology of Sex Differences. 2020;11(1):31. doi: https://doi.org/10.1186/s13293-020-00306-7
Bensken WP, Ho VP, Pieracci FM. Basic Introduction to Statistics in Medicine, Part 2: Comparing Data. Surg Infect (Larchmt). 2021;22(6):597-603. doi: https://doi.org/10.1089/sur.2020.430
Piani F, Melena I, Tommerdahl KL, et al. Sexrelated differences in diabetic kidney disease: A review on the mechanisms and potential therapeutic implications. Journal of Diabetes Complications. 2021;35(4):107841. doi: https://doi.org/10.1016/j.jdiacomp.2020.107841
Giandalia A, Giuffrida AE, Gembillo G, et al. Gender differences in diabetic kidney disease: focus on hormonal, genetic and clinical factors. International J Molec Sciences. 2021;22(11):5808. doi: https://doi.org/10.3390/ijms22115808
Menendez-Castro C, Cordasic N, Fahlbusch FB, et al. Sex differences in longterm kidney fibrosis following neonatal nephron loss during ongoing nephrogenesis. Molecular and Cellular Pediatrics. 2023;10(1):8. doi: https://doi.org/10.1186/s40348-023-00164-4
Rajabi S, Saberi S, Najafipour H, et al. Interaction of estradiol and renin-angiotensin system with microRNAs-21 and -29 in renal fibrosis: focus on TGF-β/smad signaling pathway. Molecular Biology Reports. 2024;51(1):137. doi: https://doi.org/10.1007/s11033-023-09127-4
Schexnayder CD, Agbahiwe S, Emelogu O. Burnt out? The phenomenon of type 2 diabetes mellitus in end-stage renal disease. Federal Practitioner. 2020;37(12):580-5. doi: https://doi.org/10.12788/fp.0076
Xu AR, Jin Q, Shen Z, et al. Association between the risk of hypertension and triglyceride glucose index in Chinese regions: a systematic review and dose-response meta-analysis of a regional update. Front Cardiovascular Medicine. 2023;10:1242035. doi: https://doi.org/10.3389/fcvm.2023.1242035
Swartling O, Rydell H, Stendahl M, et al. CKD Progression and mortality among men and women: a nationwide study in Sweden. Am J Kidney Dis. 2021;78(2):190-9. doi: https://doi.org/10.1053/j.ajkd.2020.11.026
Wang K, Xu W, Zha B, et al. Fibrinogen to albumin ratio as an independent risk factor for type 2 diabetic kidney disease. Diabetes Metab Syndr Obes. 2021;14:4557-67. doi: https://doi.org/10.2147/DMSO.S337986
Bernstein SR, Kelleher C, Khalil RA. Gender-based research underscores sex differences in biological processes, clinical disorders and pharmacological interventions. Biochemical Pharmacology. 2023;215:115737. doi: https://doi.org/10.1016/j.bcp.2023.115737
Christofides EA, Desai N. Optimal early diagnosis and monitoring of diabetic kidney disease in type 2 diabetes mellitus: addressing the barriers to albuminuria testing. Journal of Primary Care and Community Health. 2021;12:21501327211003683. doi: https://doi.org/10.1177/21501327211003683
Li S, Li N, Li L, Zhan J. Sex difference in the association between serum versican and albuminuria in patients with type 2 diabetes mellitus. Diabetes, Metabolic Synd¬rome and Obesity. 2023;16:3631-9. doi: https://doi.org/10.2147/DMSO.S434287
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Medicni perspektivi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
